Skip to main content
Premium Trial:

Request an Annual Quote

Tm Bioscience Licenses P450 PGx Marker From Epidauros Biotechnologie

NEW YORK, March 14 (GenomeWeb News) - Tm Bioscience said today that it has taken a co-exclusive commercial license to Epidauros Biotechnologie's patents on a specific biomarker related to the P450-CYP2D6 gene.

 

Under the terms of the agreement, Tm Bioscience will provide an upfront signing fee and royalties on sales of P450 Tag-It tests that include this biomarker.

 

Roche Molecular Systems is the only other company that has a license to the CYP2D6 genetic marker, and has incorporated the marker into its AmpliChip CYP2D6 test. Tm Bioscience and Epidauros, which is based in Bernried, Germany, have negotiated an agreement whereby no other licenses for this variant will be granted in the future, the companies said.